S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
1907, 1929, 1998, 2007--and now 2023? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
1907, 1929, 1998, 2007--and now 2023? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
1907, 1929, 1998, 2007--and now 2023? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI" (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
1907, 1929, 1998, 2007--and now 2023? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
NYSEARCA:GRN

iPath Series B Carbon ETN (GRN) Price, Holdings, & News

$32.09
-0.33 (-1.02%)
(As of 10/2/2023 ET)
Compare
Today's Range
$32.04
▼
$32.19
50-Day Range
$32.05
▼
$36.41
52-Week Range
$25.38
▼
$39.02
Volume
6,190 shs
Average Volume
6,781 shs
Market Capitalization
$94.29 million
Assets Under Management
$45.37 million
Dividend Yield
0.00%
Net Expense Ratio
0.75%
ProfileChartHeadlines

GRN Price History

GRN ETF News Headlines

September 30, 2023 | americanbankingnews.com
iPath Series B Carbon ETN (NYSEARCA:GRN) Share Price Passes Below Two Hundred Day Moving Average of $34.34
September 11, 2023 | wsj.com
Bergman & Beving AB Series B
October 3, 2023 | Behind the Markets (Ad)
The World's First "$20 Trillion Drug
?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>
July 30, 2023 | benzinga.com
iPath Series B Carbon Exchange-Traded Notes Stock (ARCA:GRN), Quotes and News Summary
July 4, 2023 | wsj.com
Sagax AB Series B
September 20, 2022 | cnbc.com
Barclays iPath Series B S&P 500 VIX Short-Term Futures
April 27, 2022 | finance.yahoo.com
KraneShares Debuts Carbon Offset ETF
January 4, 2022 | finance.yahoo.com
Best Performing ETFs of 2021
October 3, 2023 | Behind the Markets (Ad)
The World's First "$20 Trillion Drug
?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>>
December 16, 2021 | finance.yahoo.com
Best ETFs for Q1 2022
See More Headlines
Receive GRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iPath Series B Carbon ETN and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Barclays Capital
Fund Name
iPath Series B Carbon ETN
Tax Classification
Exchange-Traded Note
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:GRN
Inception Date
9/11/2019
Fund Manager
N/A
Web
www.barclays.co.uk
Phone
442071161000

Fund Focus

Asset Class
Equity
Benchmark
Barclays Global Carbon II TR USD Index
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
Global
Number of Holdings
0

Fund Statistics

Assets Under Management
$45.37 million
Average Daily Volume
$0.00
Discount/Premium
-0.08%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
1
Put Options
1
Call Options
1

Miscellaneous

Outstanding Shares
2,938,000
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

iPath Series B Carbon ETN Expenses

TypeGRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.00%0.57%0.53%0.50%0.50%
Other Expenses0.00%0.78%0.52%0.64%0.57%
Total Expense0.00%0.73%0.69%0.74%0.69%
Fee Waiver0.00%-0.81%-0.55%-0.69%-0.58%
Net Expense0.75%0.60%0.59%0.57%0.57%

iPath Series B Carbon ETN (GRN)

Full Holdings Details













GRN ETF - Frequently Asked Questions

How have GRN shares performed in 2023?

iPath Series B Carbon ETN's stock was trading at $31.63 at the beginning of the year. Since then, GRN shares have increased by 1.5% and is now trading at $32.0917.
View the best growth stocks for 2023 here.

What does GRN invest in?

iPath Series B Carbon ETN is a equity fund issued by Barclays Capital. GRN focuses on theme investments and follows the Barclays Global Carbon II TR USD Index. The fund's investments total to approximately $45.37 million assets under management.

What other stocks do shareholders of iPath Series B Carbon ETN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iPath Series B Carbon ETN investors own include Synopsys (SNPS), Sondrel (SND), Marathon Oil (MRO), Electronic Arts (EA) and

What is iPath Series B Carbon ETN's stock symbol?

iPath Series B Carbon ETN trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "GRN."

How do I buy shares of iPath Series B Carbon ETN?

Shares of GRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iPath Series B Carbon ETN's stock price today?

One share of GRN stock can currently be purchased for approximately $32.09.

How much money does iPath Series B Carbon ETN make?

iPath Series B Carbon ETN (NYSEARCA:GRN) has a market capitalization of $94.29 million.

How many employees does iPath Series B Carbon ETN have?

The company employs 2,020 workers across the globe.

How can I contact iPath Series B Carbon ETN?

iPath Series B Carbon ETN's mailing address is Canary Wharf, 1 Churchill Place, London E14 5HP. The official website for the company is www.barclays.co.uk. The exchange traded fund can be reached via phone at 442071161000.

This page (NYSEARCA:GRN) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -